These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9683837)

  • 1. The role of bcl-2 expression in breast carcinomas (Review).
    Zhang GJ; Kimijima I; Tsuchiya A; Abe R
    Oncol Rep; 1998; 5(5):1211-6. PubMed ID: 9683837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
    Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM
    Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
    Lee WY; Jin YT; Tzeng CC
    Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
    Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
    Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.
    Daidone MG; Luisi A; Veneroni S; Benini E; Silvestrini R
    Endocr Relat Cancer; 1999 Mar; 6(1):61-8. PubMed ID: 10732789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 protein in normal, hyperplastic and neoplastic breast tissues. A metabolite of the putative stem-cell subpopulation of the mammary gland.
    Luna-Moré S; Weil B; Bautista D; Garrido E; Florez P; Martínez C
    Histol Histopathol; 2004 Apr; 19(2):457-63. PubMed ID: 15024706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of immunohistochemical Bcl-2 expression in invasive breast carcinoma.
    Takei H; Oyama T; Iino Y; Horiguchi J; Hikino T; Maemura M; Nagaoka H; Iijima K; Yokoe T; Nakajima T; Morishita Y
    Oncol Rep; 1999; 6(3):575-81. PubMed ID: 10203594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy.
    Yang Q; Sakurai T; Yoshimura G; Suzuma T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
    Oncol Rep; 2003; 10(1):121-5. PubMed ID: 12469156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
    Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
    Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma].
    Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
    Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.